Literatur
- 1 Food and Drug Administration
USA. http://www.fda.gov/ohrms/dockets/ac/05/slides/5-4188S1_5.pdf
Stand: 26. Aug 2009.
- 2
Gregersen J P.
A quantitative risk assessment of exposure to adventitious agents
in a cell culture-derived subunit influenza vaccine.
Vaccine.
2008;
26
3332-40
- 3
Gregersen J P.
A risk-assessment model to rate the occurrence and relevance
of adventitious agents in the production of influenza vaccines.
Vaccine.
2008;
26
3297-304
Prof. Heinz-Josef Schmitt MD MPH FIDSA
T. F. Tsai
Dr. M. Bröker
Novartis Vaccines & Diagnostics GmbH
Emil-von-Behring-Straße
76
35041 Marburg
Email: Joe.Schmitt@Novartis.com
